1. Home
  2. AVXL vs RGCO Comparison

AVXL vs RGCO Comparison

Compare AVXL & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.40

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

HOLD

Current Price

$22.89

Market Cap

233.9M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
RGCO
Founded
2004
1912
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
289.1M
233.9M
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
AVXL
RGCO
Price
$3.40
$22.89
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$22.00
$22.70
AVG Volume (30 Days)
2.0M
7.9K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
3.88%
EPS Growth
N/A
11.21
EPS
N/A
0.47
Revenue
N/A
$95,334,212.00
Revenue This Year
N/A
$11.06
Revenue Next Year
N/A
$2.89
P/E Ratio
N/A
$47.77
Revenue Growth
N/A
12.63
52 Week Low
$2.61
$19.68
52 Week High
$13.99
$24.00

Technical Indicators

Market Signals
Indicator
AVXL
RGCO
Relative Strength Index (RSI) 47.74 52.37
Support Level $2.93 $20.93
Resistance Level $4.88 $22.80
Average True Range (ATR) 0.18 0.72
MACD 0.06 0.07
Stochastic Oscillator 98.62 47.96

Price Performance

Historical Comparison
AVXL
RGCO

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

Share on Social Networks: